The association between immune markers and recent suicide attempts in patients with serious mental illness: A pilot study

Psychiatry Research

Volumn 255, Issue , 2017, Pages 8-12

  Dickerson, Faith ^a   Adamos, Maria ^a   Katsafanas, Emily ^a   Khushalani, Sunil ^a   Origoni, Andrea ^a   Savage, Christina ^a   Schweinfurth, Lucy ^a   Stallings, Cassie ^a   Sweeney, Kevin ^a   Alaedini, Armin ^b   Uhde, Melanie ^b   Severance, Emily ^c   Wilcox, Holly C ^c   Yolken, Robert ^c  

^a SHEPPARD PRATT HEALTH SYSTEM   (United States)

^b Columbia University ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attempted; Biomarkers; Gastrointestinal; Inflammation; Suicide

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLIADIN; MANNAN; AUTACOID;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PILOT STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SUICIDE ATTEMPT; BLOOD; CASE CONTROL STUDY; GASTROINTESTINAL TRACT; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; BIOMARKERS; BIPOLAR DISORDER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE, ATTEMPTED;

EID: 85019070732     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2017.05.005     Document Type: Article

References (39)

1. Arling, T.A., Yolken, R.H., Lapidus, M., Langenberg, P., Dickerson, F.B., Zimmerman, S.A., et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J. Nerv. Ment. Dis. 197:12 (2009), 905–908.
2. Black, C., Miller, B.J., Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients. Biol. Psychiatry 78:1 (2015), 28–37.
3. Carson, H.J., Dudley, M.H., Knight, L.D., Lingamfelter, D., Psychosocial complications of Crohn's disease and cause of death. J. Forensic Sci. 59:2 (2014), 568–570.
4. Cavanagh, J.T., Carson, A.J., Sharpe, M., Lawrie, S.M., Psychological autopsy studies of suicide: a systematic review. Psychol. Med. 33:3 (2003), 395–405.
5. Courtet, P., Giner, L., Seneque, M., Guillaume, S., Olie, E., Ducasse, D., Neuroinflammation in suicide: toward a comprehensive model. World J. Biol. Psychiatry 17:8 (2016), 564–586.
6. Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Leister, F., et al. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol. Psychiatry 68:1 (2010), 100–104.
7. Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Alaedini, A., et al. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord. 13:1 (2011), 52–58.
8. Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Yolken, R., Markers of gluten sensitivity in acute mania: a longitudinal study. Psychiatry Res. 196:1 (2012), 68–71.
9. Dickerson, F., Stallings, C., Origoni, A., Katsafanas, E., Schweinfurth, L.A., Savage, C.L., et al. Association between cytomegalovirus antibody levels and cognitive functioning in non-elderly adults. PLoS One, 9(5), 2014, e95510.
10. Dickerson, F., Stallings, C., Origoni, A., Katsafanas, E., Schweinfurth, L., Savage, C., et al. Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. J. Nerv. Ment. Dis. 202:8 (2014), 589–593.
11. Dickerson, F., Stallings, C., Origoni, A., Schroeder, J., Katsafanas, E., Schweinfurth, L., et al. Inflammatory markers in recent onset psychosis and chronic schizophrenia. Schizophr. Bull. 42:1 (2016), 134–141.
12. Dickerson, F., Wilcox, H.C., Adamos, M., Katsafanas, E., Khushalani, S., Origoni, A., et al. Suicide attempts and markers of immune response in individuals with serious mental illness. J. Psychiatr. Res. 87 (2016), 37–43.
13. First, M.B., Gibbon, M., Spitzer, R.L., Williams, J.B.W., Structured Clinical Interview for DSM-IV Disorders, Non-Patient Edition. 1998, Biometrics Research, N.Y. State Psychiatric Institute, New York, NY.
14. Fuller-Thomson, E., Sulman, J., Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm. Bowel Dis. 12:8 (2006), 697–707.
15. Gananca, L., Oquendo, M.A., Tyrka, A.R., Cisneros-Trujillo, S., Mann, J.J., Sublette, M.E., The role of cytokines in the pathophysiology of suicidal behavior. Psychoneuroendocrinology 63 (2016), 296–310.
16. Garcia Bueno, B., Caso, J.R., Madrigal, J.L., Leza, J.C., Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases. Neurosci. Biobehav. Rev. 64 (2016), 134–147.
17. Gibney, S.M., Drexhage, H.A., Evidence for a dysregulated immune system in the etiology of psychiatric disorders. J. Neuroimmune Pharmacol. 8:4 (2013), 900–920.
18. Gradus, J.L., Qin, P., Lincoln, A.K., Miller, M., Lawler, E., Sorensen, H.T., et al. Inflammatory bowel disease and completed suicide in Danish adults. Inflamm. Bowel Dis. 16:12 (2010), 2158–2161.
19. Haapakoski, R., Ebmeier, K.P., Alenius, H., Kivimaki, M., Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances. Prog. Neuropsychopharmacol. Biol. Psychiatry 66 (2016), 63–72.
20. Kaul, A., Hutfless, S., Liu, L., Bayless, T.M., Marohn, M.R., Li, X., Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis. Inflamm. Bowel Dis. 18:10 (2012), 1872–1884.
21. Kiecolt-Glaser, J.K., Derry, H.M., Fagundes, C.P., Inflammation: depression fans the flames and feasts on the heat. Am. J. Psychiatry 172:11 (2015), 1075–1091.
22. Lakatos, P.L., Kiss, L.S., Palatka, K., Altorjay, I., Antal-Szalmas, P., Palyu, E., et al. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease. Inflamm. Bowel Dis. 17:3 (2011), 767–777.
23. Leboyer, M., Berk, M., Yolken, R.H., Tamouza, R., Kupfer, D., Groc, L., Immuno-psychiatry: an agenda for clinical practice and innovative research. BMC Med., 14(1), 2016, 173.
24. Liu, J., Liang, Q., Frost-Pineda, K., Muhammad-Kah, R., Rimmer, L., Roethig, H., et al. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol. Biomark. Prev. 20:8 (2011), 1760–1769.
25. Ludvigsson, J.F., Sellgren, C., Runeson, B., Langstrom, N., Lichtenstein, P., Increased suicide risk in coeliac disease–a Swedish nationwide cohort study. Dig. Liver Dis. 43:8 (2011), 616–622.
26. Mullins, N., Perroud, N., Uher, R., Butler, A.W., Cohen-Woods, S., Rivera, M., et al. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165B:5 (2014), 428–437.
27. Nordentoft, M., Mortensen, P.B., Pedersen, C.B., Absolute risk of suicide after first hospital contact in mental disorder. Arch. Gen. Psychiatry 68:10 (2011), 1058–1064.
28. O'Donovan, A., Rush, G., Hoatam, G., Hughes, B.M., McCrohan, A., Kelleher, C., et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depression Anxiety 30:4 (2013), 307–314.
29. Oquendo, M.A., Sullivan, G.M., Sudol, K., Baca-Garcia, E., Stanley, B.H., Sublette, M.E., et al. Toward a biosignature for suicide. Am. J. Psychiatry 171:12 (2014), 1259–1277.
30. Overall, J.E., Gorham, D.R., The brief psychiatric rating scale. Psychol. Rep. 10 (1962), 799–812.
31. Petra, A.I., Panagiotidou, S., Hatziagelaki, E., Stewart, J.M., Conti, P., Theoharides, T.C., Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin. Ther. 37:5 (2015), 984–995.
32. Posner, K., Brown, G.K., Stanley, B., Brent, D.A., Yershova, K.V., Oquendo, M.A., et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am. J. Psychiatry 168:12 (2011), 1266–1277.
33. Randolph, C., Tierney, M.C., Mohr, E., Chase, T.N., The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20:3 (1998), 310–319.
34. Severance, E.G., Gressitt, K.L., Stallings, C.R., Origoni, A.E., Khushalani, S., Leweke, F.M., et al. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr. Res. 148:1–3 (2013), 130–137.
35. Severance, E.G., Gressitt, K.L., Yang, S., Stallings, C.R., Origoni, A.E., Vaughan, C., et al. Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord. 16:3 (2014), 230–240.
36. Severance, E.G., Prandovszky, E., Castiglione, J., Yolken, R.H., Gastroenterology issues in schizophrenia: why the gut matters. Curr. Psychiatry Rep., 17(5), 2015, 27.
37. Triantafillidis, J.K., Hyphantis, T., Cheracakis, P., Antoniou, A., Sklavaina, M., Suicide as an outcome in patients with inflammatory bowel disease. Am. J. Gastroenterol. 97:4 (2002), 1066–1068.
38. Uhde, M., Ajamian, M., Caio, G., De Giorgio, R., Indart, A., Green, P.H., et al. Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease. Gut 65:12 (2016), 1930–1937.
39. Zalsman, G., Hawton, K., Wasserman, D., van Heeringen, K., Arensman, E., Sarchiapone, M., Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry 3:7 (2016), 646–659.